Mrv1909 11242221172D 20 19 0 0 1 0 999 V2000 3.2151 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2151 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5006 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5006 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 -0.4125 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.0717 -0.4125 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.3572 -0.8250 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.7861 1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.5006 -1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.5006 0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 -1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7861 -0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 -0.8250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 -1.2375 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 0.0000 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 -1.2375 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 4 3 1 0 0 0 0 6 1 1 0 0 0 0 7 2 1 0 0 0 0 8 5 1 0 0 0 0 9 3 1 0 0 0 0 10 8 1 0 0 0 0 10 9 1 0 0 0 0 11 4 2 0 0 0 0 12 6 2 0 0 0 0 13 7 2 0 0 0 0 8 14 1 0 0 0 0 10 15 1 0 0 0 0 16 5 1 0 0 0 0 16 6 1 0 0 0 0 17 7 1 0 0 0 0 9 17 1 0 0 0 0 8 18 1 1 0 0 0 9 19 1 1 0 0 0 10 20 1 6 0 0 0 M END > DB17192 > drugbank > [H][C@@](O)(COC(C)=O)[C@@]([H])(O)[C@@]([H])(CC=O)OC(C)=O > InChI=1S/C10H16O7/c1-6(12)16-5-8(14)10(15)9(3-4-11)17-7(2)13/h4,8-10,14-15H,3,5H2,1-2H3/t8-,9-,10-/m1/s1 > BYPTXUKSDKAPKO-OPRDCNLKSA-N > C10H16O7 > 248.231 > 248.089602855 > 5 > 33 > -1.3146369446636756e-06 > 23.354368581827025 > 1 > 2 > 0 > 0 > (3R,4R,5R)-6-(acetyloxy)-4,5-dihydroxy-1-oxohexan-3-yl acetate > -0.72 > -1.9709512816666668 > -0.46 > 0 > 0 > 0 > 0 > 14.35808691156093 > 12.90518799939591 > -3.531566236525625 > 110.13000000000001 > 54.3104 > 9 > 1 > 8.64e+01 g/l > altiratinib > 0 > DB17192 > investigational > WP-1122 > 3,6-di-O-acetyl-2-deoxy-D-glucopyranose; an acetic acid diester of 2-deoxy-D-glucose $$$$